All of the following conditions are contraindicated or likely to women in a case of Primary Open Angle glaucoma, when treated with Timolol maleate 0.5% eye drops, except –
**Core Concept**
Primary Open Angle glaucoma (POAG) is a condition characterized by progressive optic nerve damage due to increased intraocular pressure (IOP). Timolol maleate 0.5% eye drops are a beta-blocker used to reduce IOP by decreasing aqueous humor production. However, beta-blockers can have systemic effects, particularly in women, due to their impact on the cardiovascular and respiratory systems.
**Why the Correct Answer is Right**
In women, especially those with a history of cardiovascular disease or respiratory conditions, beta-blockers like Timolol maleate can exacerbate existing conditions. This is because beta-blockers can slow heart rate, reduce cardiac output, and worsen respiratory function. In women with a history of asthma or COPD, beta-blockers can trigger bronchospasm, leading to respiratory distress. However, in the case of POAG, the benefits of reducing IOP often outweigh the risks, but certain conditions are contraindicated.
**Why Each Wrong Option is Incorrect**
**Option A:** **Systemic lupus erythematosus (SLE)** is not a direct contraindication for Timolol maleate. While SLE patients may be on various medications, beta-blockers are not typically contraindicated in SLE.
**Option B:** **Asthma** is a contraindication for Timolol maleate due to the risk of bronchospasm. Beta-blockers can trigger asthma attacks, making this option correct.
**Option C:** **Hyperthyroidism** is not a direct contraindication for Timolol maleate. However, it's essential to monitor thyroid function in patients taking beta-blockers, as they can mask symptoms of hyperthyroidism.
**Option D:** **Hypertension** is not a contraindication for Timolol maleate. In fact, beta-blockers are often used to treat hypertension, making this option incorrect.
**Clinical Pearl / High-Yield Fact**
When prescribing beta-blockers like Timolol maleate for glaucoma, it's crucial to assess the patient's cardiovascular and respiratory status, particularly in women with a history of asthma, COPD, or cardiovascular disease. Regular monitoring of IOP and systemic effects is essential to minimize risks.
**Correct Answer: B. Asthma**